Provided by Tiger Trade Technology Pte. Ltd.

RCN Pareto Strategic Allocation ETF

26.76
+0.10910.41%
Volume:4.63K
Turnover:123.85K
Market Cap:14.64M
PE:- -
High:26.80
Open:26.76
Low:26.69
Close:26.65
52wk High:26.80
52wk Low:24.68
Shares:547.19K
Float Shares:547.19K
Volume Ratio:1.72
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
RCN Pareto Strategic Allocation ETF
Exchange:
ARCA
Establishment Date:
- -
Employees:
- -
Office Location:
234 West Florida Street,Suite 203,Milwaukee,Wisconsin,United States
Zip Code:
53204
Phone:
- -
Fax:
- -
Introduction:
Proteon Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular diseases. It develops vonapanitase, a recombinant human elastase, which is in two Phase III clinical trials in patients with chronic kidney disease undergoing surgical creation of a radiocephalic arteriovenous fistula for hemodialysis; has completed a Phase I/II clinical trials for the treatment of patients undergoing arteriovenous graft placement; and has completed Phase I clinical trial for the treatment of symptomatic peripheral artery diseases. The company was founded in 2001 and is headquartered in Waltham, Massachusetts.